3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
76
Phase 2
8
Phase 3
4
Phase 2/3
2
Phase 1/2
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
117
Triple Negative Breast Neoplasms
9
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
HER2-positive Breast Cancer
4
Prostatic Neoplasms
3
Motor Activity
3
Melanoma
3
Inflammatory Breast Neoplasms
3
Head and Neck Neoplasms
3
Depression
3
Colorectal Neoplasms
3
Sarcoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Fatigue
2
Carcinoma, Ductal, Breast
2
Breast Diseases
2
Breast Carcinoma In Situ
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Incontinence
1
To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
1
Smoking
1
Sleepiness
1
Seroma
1
Recurrence
1
Radiodermatitis
1
Interventions
Mindfulness-Based Stress Reduction
1
Melatonin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Anxiety Disorders
×
Breast
×
Clear all
NCT00990977
2015-06-30
MICA
Danish Cancer Society
Phase 2/3
Completed
336 enrolled
NCT01355523
2014-05-06
MELODY
Herlev Hospital
Phase 2/3
Terminated
54 enrolled
27 charts